Results
|
2441.
|
|
|
2442.
|
|
|
2443.
|
|
|
2444.
|
|
|
2445.
|
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash. [electronic resource] by
- Steffens, Michael
- Paul, Tanusree
- Hichert, Vivien
- Scholl, Catharina
- von Mallek, Dirk
- Stelzer, Christoph
- Sörgel, Fritz
- Reiser, Bärbel
- Schumann, Christian
- Rüdiger, Stefan
- Boeck, Stefan
- Heinemann, Volker
- Kächele, Volker
- Seufferlein, Thomas
- Stingl, Julia
Producer: 20160629
In:
European journal of cancer (Oxford, England : 1990) vol. 55
Availability: No items available.
|
|
2446.
|
|
|
2447.
|
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial. [electronic resource] by
- Dillinger, Jean-Guillaume
- Ducrocq, Gregory
- Elbez, Yedid
- Cohen, Marc
- Bode, Christoph
- Pollack, Charles
- Nicolau, José C
- Henry, Patrick
- Kedev, Sasko
- Wiviott, Stephen D
- Sabatine, Marc S
- Mehta, Shamir R
- Steg, Philippe Gabriel
Producer: 20190826
In:
Circulation. Cardiovascular interventions vol. 11
Availability: No items available.
|
|
2448.
|
|
|
2449.
|
|
|
2450.
|
Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction. [electronic resource] by
- Han, Seong Woo
- Choi, Suk-Won
- Ryu, Kyu-Hyung
- Kim, Hyun-Joong
- Kim, Sung Hea
- Shim, Wan Joo
- Cha, Tae-Joon
- Choi, Dong-Ju
- Kim, Yong-Jin
- Yoo, Byung-Su
- Kim, Jun-Hyung
- Hwang, Kyung-Kuk
- Jeon, HuiKyung
- Shin, Mi-Seung
Producer: 20170206
In:
Cardiovascular therapeutics vol. 34
Availability: No items available.
|
|
2451.
|
|
|
2452.
|
|
|
2453.
|
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study. [electronic resource] by
- Jakubowski, Joseph A
- Angiolillo, Dominick J
- Zhou, Chunmei
- Small, David S
- Moser, Brian A
- Ten Berg, Jurrien M
- Brown, Patricia B
- James, Stefan
- Winters, Kenneth J
- Erlinge, David
Producer: 20160509
In:
Thrombosis research vol. 134
Availability: No items available.
|
|
2454.
|
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants. [electronic resource] by
- Devineni, Damayanthi
- Manitpisitkul, Prasarn
- Vaccaro, Nicole
- Bernard, Apexa
- Skee, Donna
- Mamidi, Rao N V S
- Tian, Hong
- Weiner, Sveta
- Stieltjes, Hans
- Sha, Sue
- Rothenberg, Paul
Producer: 20150818
In:
International journal of clinical pharmacology and therapeutics vol. 53
Availability: No items available.
|
|
2455.
|
|
|
2456.
|
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. [electronic resource] by
- Steinberg, Benjamin A
- Holmes, Dajuanicia N
- Piccini, Jonathan P
- Ansell, Jack
- Chang, Paul
- Fonarow, Gregg C
- Gersh, Bernard
- Mahaffey, Kenneth W
- Kowey, Peter R
- Ezekowitz, Michael D
- Singer, Daniel E
- Thomas, Laine
- Peterson, Eric D
- Hylek, Elaine M
Producer: 20140616
In:
Journal of the American Heart Association vol. 2
Availability: No items available.
|
|
2457.
|
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. [electronic resource] by
- Ferder, N S
- Eby, C S
- Deych, E
- Harris, J K
- Ridker, P M
- Milligan, P E
- Goldhaber, S Z
- King, C R
- Giri, T
- McLeod, H L
- Glynn, R J
- Gage, B F
Producer: 20100520
In:
Journal of thrombosis and haemostasis : JTH vol. 8
Availability: No items available.
|
|
2458.
|
|
|
2459.
|
|
|
2460.
|
|